[Clinical and immunological aspects of surgical treatment of stomach and duodenal ulcer].
Of 182 examined patients with the stomach and duodenum ulcer disease (UD) 104 (57.14%) of whom with complications. Antiulcerous antibodies were determined in patients according to results obtained in passive hemagglutination reaction (PHAR) using erythrocytic diagnosticums. In patients with gastric and duodenal UD the antitissue antibodies to corresponding antigens from gastric and duodenal ulcers were determined before the operation. The incidence of antibodies discovery depends on the patients condition. In 18 months after the operation the percentage of PHAR positive results have reduced down to 72.5% on average.
Shaposhnikov
A V
AV
Moskalenko
E P
EP
Matveev
N V
NV
D000937:Antigen-Antibody Reactions / Q000276:immunology; D004381:Duodenal Ulcer / Q000150:complications / Q000276:immunology / Q000601:surgery*; D005743:Gastrectomy; D006386:Hemagglutination Tests; D006801:Humans; D010438:Peptic Ulcer Hemorrhage / Q000276:immunology / Q000601:surgery*; D010439:Peptic Ulcer Perforation / Q000276:immunology / Q000601:surgery*; D013276:Stomach Ulcer / Q000150:complications / Q000276:immunology / Q000601:surgery*; D016896:Treatment Outcome; D014629:Vagotomy, Proximal Gastric; D015167:Vagotomy, Truncal